Volume 14, Issue 9 (November 2020)
Qom Univ Med Sci J 2020, 14(9): 16-27 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mirazi N, Mosalsal S, Izadi Z, Nourian A. Protective Effect of Hydroethanolic Extract of Lippia citrodora L. Leaf and Vitamin D3 on Estradiol Valerate-Induced Polycystic Ovary Syndrome in Mice. Qom Univ Med Sci J 2020; 14 (9) :16-27
URL: http://journal.muq.ac.ir/article-1-2927-en.html
URL: http://journal.muq.ac.ir/article-1-2927-en.html
1- Department of Biology, Faculty of Basic Sciences, Bu-Ali Sina University , mirazi205@gmail.com
2- Department of Biology, Faculty of Basic Sciences, Bu-Ali Sina University
3- Department of Horticulture Sciences, Faculty of Agriculture, University of Nahavand
4- Department of Pathobiology, Faculty of Veterinary Medicine, Bu-Ali Sina University
2- Department of Biology, Faculty of Basic Sciences, Bu-Ali Sina University
3- Department of Horticulture Sciences, Faculty of Agriculture, University of Nahavand
4- Department of Pathobiology, Faculty of Veterinary Medicine, Bu-Ali Sina University
Abstract: (2990 Views)
Background and Objectives: This study was conducted to investigate the protective effect of hydroethanolic extract of Lippia citrodora L. leaf (LCE) and vitamin D3 on polycystic ovary syndrome (PCOS) in suri rats.
Methods: This experimental study was performed on 48 female suri rats with a weight range of 25-35g. The subjects were divided into 8 groups (n=6 each), namely control (food + water), case (estradiol valerate, subcutaneously), sham (sesame oil, 0.25 ml, subcutaneously), positive control (metformin + water), intervention 1 (estradiol valerate + low-dose Lippia citrodora L. extract, intraperitoneally), intervention 2 (estradiol valerate + LCE high dose, intraperitoneally), intervention 3 (estradiol valerate + vitamin D3, intraperitoneally), and intervention 4 (estradiol valerate + Lippia citrodora L. extract + vitamin D3). The whole process of performing the experiments took 55 days. To conduct the study, blood and ovary tissue samples were obtained from the subjects. The collected data were analyzed in SPSS software (version 24) using the one-way ANOVA method.
Results: Based on the results of the study, estradiol valerate caused PCOS in suri rats. Moreover, a significant decrease of ovarian cysts was observed in the ovarian tissue of the treatment groups, compared to those in the case group. It was also found out the concomitant use of Lippia citrodora L. extract and vitamin D3 was more effective in reducing ovarian cysts.
Conclusion: The results of this study showed that the use of Lippia citrodora L. extract and vitamin D3 had a significant effect on reducing ovarian cysts in suri rats with PCOS.
Methods: This experimental study was performed on 48 female suri rats with a weight range of 25-35g. The subjects were divided into 8 groups (n=6 each), namely control (food + water), case (estradiol valerate, subcutaneously), sham (sesame oil, 0.25 ml, subcutaneously), positive control (metformin + water), intervention 1 (estradiol valerate + low-dose Lippia citrodora L. extract, intraperitoneally), intervention 2 (estradiol valerate + LCE high dose, intraperitoneally), intervention 3 (estradiol valerate + vitamin D3, intraperitoneally), and intervention 4 (estradiol valerate + Lippia citrodora L. extract + vitamin D3). The whole process of performing the experiments took 55 days. To conduct the study, blood and ovary tissue samples were obtained from the subjects. The collected data were analyzed in SPSS software (version 24) using the one-way ANOVA method.
Results: Based on the results of the study, estradiol valerate caused PCOS in suri rats. Moreover, a significant decrease of ovarian cysts was observed in the ovarian tissue of the treatment groups, compared to those in the case group. It was also found out the concomitant use of Lippia citrodora L. extract and vitamin D3 was more effective in reducing ovarian cysts.
Conclusion: The results of this study showed that the use of Lippia citrodora L. extract and vitamin D3 had a significant effect on reducing ovarian cysts in suri rats with PCOS.
Type of Study: Original Article |
Subject:
فیزیولوژی
Received: 2020/09/15 | Accepted: 2020/11/2 | Published: 2020/11/30
Received: 2020/09/15 | Accepted: 2020/11/2 | Published: 2020/11/30
References
1. References:
2. Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol 2014;6:1-13. PMID: 24379699 [DOI:10.2147/CLEP.S37559]
3. Hudecova M, Holte J, Olovsson M, Larsson A, Berne C, Poromaa IS. Diabetes and impaired glucose tolerance in patients with polycystic ovary syndrome-a long term follow-up. Hum Reprod 2011;26(6):1462-8. PMID: 21427116 [DOI:10.1093/humrep/der065]
4. Gambineri A, Patton L, Altieri P, Pagotto U, Pizzi C, Manzoli L, et al. Polycystic ovary syndrome is a risk factor for type 2 diabetes. Diabetes 2012;61(9):2369-74. PMID: 22698921 [DOI:10.2337/db11-1360]
5. Goodarzi MO, Dumesic DA, Chazenbalk G. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 2011;7(4):219-31. PMID: 21263450 [DOI:10.1038/nrendo.2010.217]
6. Daniilidis A, Dinas K. Long term health consequences of polycystic ovarian syndrome: a review analysis. Hippokratia 2009;13(2):90-2. PMID: 19561777
7. Shi Y, Cui Y, Sun X, Ma G, Ma Z, Gao Q, et al. Hypertension in women with polycystic ovary syndrome: prevalence and associated cardiovascular risk factors. Eur J Obstet Gynecol Reprod Biol 2014;173:66-70. PMID: 24368020 [DOI:10.1016/j.ejogrb.2013.11.011]
8. Chittenden BG, Fullerton G, Maheshwari A, Bhattacharya S. Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review. Reprod Biomed Online 2009;19(3):398-405. PMID: 19778486 [DOI:10.1016/S1472-6483(10)60175-7]
9. Haoula Z, Salman M, Atiomo W. Evaluating the association between endometrial cancer and polycystic ovary syndrome. Hum Reprod 2012;27(5):1327-31. PMID: 22367984 [DOI:10.1093/humrep/des042]
10. Amin B, Noorani R, Razavi BM, Hosseinzadeh H. The effect of ethanolic extract of Lippia citriodora on rats with chronic constriction injury of neuropathic pain. Cell J 2018;19(4): 528-36. PMID: 29105386
11. Lin MW, Wu MH. The role of vitamin D in polycystic ovary syndrome. Indian J Med Res 2015;142(3):238-40. PMID: 26458338 [DOI:10.4103/0971-5916.166527]
12. Alvarez JA, Ashraf AP, Hunter GR, Gower BA. Serum 25-hydroxyvitamin D and parathyroid hormone are independent determinants of whole-body insulin sensitivity in women and may contribute to lower insulin sensitivity in African Americans. Am J Clin Nutr 2010;92(6):1344-9. PMID: 20861177 [DOI:10.3945/ajcn.110.000976]
13. Behmanesh N, Abedelahi A, Nozad Charoudeh H, Alireza Alihemmati A. Effects of vitamin D supplementation on follicular development, gonadotropins and sex hormone concentrations, and insulin resistance in induced polycystic ovary syndrome. Turk J Obstet Gynecol 2019;16(3):143-50. PMID: 31673465 [DOI:10.4274/tjod.galenos.2019.46244]
14. Lee KM, Hwang MK, Lee DE, Lee KW, Lee HJ. Protective effect of quercetin against arsenite-induced COX-2 expression by targeting PI3K in rat liver epithelial cells. J Agric Food Chem 2010;58(9):5815-20. PMID: 20377179 [DOI:10.1021/jf903698s]
15. Geraets L, Moonen HJ, Brauers K, Wouters EF, Bast A, Hageman GJ. Dietary flavones and flavonols are inhibitor of poly (ADP-ribose) polymerase-1 in pulmonary epithelial cells. J Nutr 2007;137(10):2190-5. PMID: 17884996 [DOI:10.1093/jn/137.10.2190]
16. Nair MP, Kandaswami C, Mahajan S, Chadha KC, Chawda R, Nair H, et al. The flavonoid, quercetin, differentially regulates Th-1 (IFNg) and Th-2 (IL4) cytokine gene expression by normal peripheral blood mononuclear cells. Biochim Biophys Acta 2002;1593(1):29-36. PMID: 12431781 [DOI:10.1016/S0167-4889(02)00328-2]
17. Sadoughi S. Effects of crocin on ovarian follicle and serum sex hormone in letrozole-induced polycystic ovarian syndrome in rat model. J Ardabil Univ Med Sci 2017;17(2):198-210. Link
18. Ghafurniyan H, Azarnia M, Nabiuni M, Karimzadeh L. The effect of green tea extract on reproductive improvement in estradiol valerate-induced polycystic ovarian syndrome in rat. Iran J Pharm Res 2015;14(4):1215-33. PMID: 26664389
19. Espinoza JA, Alvarado W, Venegas B, Roberto Domínguez R, Morales-Ledesma L. Pharmacological sympathetic denervation prevents the development of polycystic ovarian syndrome in rats injected with estradiol valerate. Reprod Biol Endocrinol 2018;16(1):86. PMID: 30193590 [DOI:10.1186/s12958-018-0400-8]
20. Leyva-Jiménez FJ, Lozano-Sánchez J, Cádiz-Gurrea M, Arráez-Román D, Segura-Carretero A. Functional Ingredients based on Nutritional Phenolics. A case study against inflammation: Lippia genus. Nutrients 2019;11(7):1646. PMID: 31323877 [DOI:10.3390/nu11071646]
21. Hyppönen E, Power C. Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr 2007;85:860-8. PMID: 17344510 [DOI:10.1093/ajcn/85.3.860]
22. Lerchbaum E, Obermayer-Pietsch B. Vitamin D and fertility: a systematic review. Eur J Endocrinol 2012;166(5):765-78. PMID: 22275473 [DOI:10.1530/EJE-11-0984]
23. Selimoglu H, Duran C, Kiyici S, Ersoy C, Guclu M, Ozkaya G, et al. The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome. J Endocrinol Invest 2010;33(4):234-8. PMID: 19820295 [DOI:10.1007/BF03345785]
24. Mirazi N, Shamekhi Rajabpoor S, Izadi Z. Effect of hydroethanolic extract of Jujube Fruit (Zizyphus jujube L.) in rat with polycystic ovary syndrome. Armaghane Danesh 2020;24(5):746-62. Link
25. Cádiz-Gurrea ML, Alañón-Pardo E, Arráez-Román D, Fernández-Arroyo S, Micol-Molina V, Roche E. Bioactive compounds from Lippia citriodora: application in diseases prevention. Occurrences, structure, biosynthesis, and health benefits based on their evidences of medicinal phytochemicals in vegetables and fruits. New York: Nova Science Publisher; 2017. Link
26. Russo M, Galletti GC. Medicinal properties and chemical composition of vitexegnus-castus L. a review. Int Symposium Med Aromatic Plants 1996;426:105-12. Link [DOI:10.17660/ActaHortic.1996.426.11]
27. Jelodar GH, Karami E. Effect of hydroalcoholic extract of vitex agnus-castus fruit on ovarian histology in rat with induced Polycystic Ovary Syndrome (PCOS). J Babol Univ Med Sci 2013;15(3):96-102. Link
28. Babaei Abrak S, Zhiani R. Investigation of chemical composition of Lippia citriodora: essential oil of Lippia citriodora promote survival of PC12 cells following treatment with H2O2. Neurosci J Shafaye Khatam 2014;2(1):31-9. Link [DOI:10.18869/acadpub.shefa.2.1.31]
29. Fitsiou E, Mitropoulou G, Spyridopoulou K, Vamvakias M, Bardouki H, Galanis A, et al. Chemical composition and evaluation of the biological properties of the essential oil of the dietary phytochemical Lippia citriodora. Molecules 2018;23(1):123. PMID: 29329229 [DOI:10.3390/molecules23010123]
30. Skaltsa H, Shammas G. Flavonoids from Lippia citriodora. Planta Med 1988;54(5):465. PMID: 17265320 [DOI:10.1055/s-2006-962505]
31. Sammar M, Abu-Farich B, Rayan I, Falah M, Rayan A. Correlation between cytotoxicity in cancer cells and free radical-scavenging activity: In vitro evaluation of 57 medicinal and edible plant extracts. Oncol Lett 2019;18(6):6563-71. PMID: 31819777 [DOI:10.3892/ol.2019.11054]
32. Eidi M, Kavgani AI, Shahabzadeh S, Sasaninezhad Z, Ghahramani R, Nomani MH. Effect of Lippia Citriodora on anxiety behaviour in adult male rats. Med J Tabriz Univ Med Sci Health Serv 2014;36(5):68-73. Link
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Owned by Qom University of Medical Sciences
Published by Qom University of Medical Sciences Press
eISSN: 2008-1375
pISSN: 1735-7799
Email: journal[at]muq.ac.ir
j.mua.ac[at]gmail.com
